[{"Assets_0_Q2_USD":315721000.0,"CommonStockSharesOutstanding_0_Q2_shares":156442332.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-51622000.0,"NetIncomeLoss_1_Q2_USD":12283000.0,"NetIncomeLoss_2_Q2_USD":-47001000.0,"StockholdersEquity_0_Q2_USD":-219367000.0,"Ticker":"IRWD","CIK":"1446847","name":"IRONWOOD PHARMACEUTICALS INC","OfficialName":"Ironwood Pharmaceuticals Inc. Class A Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1913848067.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190730"}]